FDA OKs New Therapy for Some Hemophilia Patients - NBC 7 San Diego
National & International News
The day’s top national and international news

FDA OKs New Therapy for Some Hemophilia Patients

Genentech, the drug's developer, says the list price will be about $482,000 for the first year and slightly less after that

    processing...

    NEWSLETTERS

    Chargers Make Unexpected Kicking Change
    AP/Genentech, Inc.
    This photo provided by Genentech, Inc. shows a package of the drug Hemlibra. On Thursday, Nov. 16, 2017, the Food and Drug Administration approved Hemlibra, the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder.

    U.S. regulators have approved the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder.

    The Food and Drug Administration on Thursday approved Hemlibra (hem-LEE'-bruh), a weekly injection for hemophilia A patients who have developed resistance to standard medicines.

    Genentech, the drug's developer, says the list price will be about $482,000 for the first year and slightly less after that.

    Genentech, a subsidiary of Swiss drugmaker Roche, says that's half the cost of the only other option for patients with this resistance. That treatment requires an IV drip several times a week.

    Rescuers Pull Leopard Out of 30-Foot Well in India

    [NATL] Rescuers Pull Leopard Out of 30-Foot Well in India

    A leopard was saved from drowning after local rescuers managed to pull it out of a 30-foot well in Maharashtra, India.

    (Published Monday, Oct. 15, 2018)

    Hemophilia mostly affects males.